Systemic therapy in retroperitoneal sarcoma management.

View/ Open
Publication Date
2018-01Author
Constantinidou, A
Jones, RL
Type
Journal Article
Metadata
Show full item recordAbstract
There is paucity of randomized controlled data on the role of systemic therapy in retroperitoneal sarcomas. The type of systemic therapy used is guided by the histological subtype. The majority of retroperitoneal sarcomas comprising liposarcomas and leiomyosarcomas are by and large chemotherapy insensitive. There is an urgent need for more efficacious systemic therapies in the management of early and advanced stage retroperitoneal sarcomas.
Collections
Version of record
Subject
Humans
Sarcoma
Retroperitoneal Neoplasms
Combined Modality Therapy
Disease Management
Research team
Sarcoma Clinical Trials (R Jones)
Language
eng
Date accepted
2017-11-02
License start date
2018-01
Citation
Journal of surgical oncology, 2018, 117 (1), pp. 87 - 92